Corey N. Fishman
2019
In 2019, Corey N. Fishman earned a total compensation of $1.4M as President and Chief Executive Officer at Iterum Therapeutics plc, a 21% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $151,841 |
---|---|
Option Awards | $561,000 |
Salary | $551,138 |
Stock Awards | $123,150 |
Other | $4,902 |
Total | $1,392,031 |
Fishman received $561K in option awards, accounting for 40% of the total pay in 2019.
Fishman also received $151.8K in non-equity incentive plan, $551.1K in salary, $123.2K in stock awards and $4.9K in other compensation.
Rankings
In 2019, Corey N. Fishman's compensation ranked 7,699th out of 13,971 executives tracked by ExecPay. In other words, Fishman earned more than 44.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,699 out of 13,971 | 45th |
Division Manufacturing | 3,003 out of 5,701 | 47th |
Major group Chemicals And Allied Products | 1,130 out of 2,200 | 49th |
Industry group Drugs | 964 out of 1,886 | 49th |
Industry Pharmaceutical Preparations | 715 out of 1,398 | 49th |
Source: SEC filing on May 7, 2020.
Fishman's colleagues
We found two more compensation records of executives who worked with Corey N. Fishman at Iterum Therapeutics plc in 2019.